Business Description
Limes Schlosskliniken AG
ISIN : DE000A0JDBC7
Share Class Description:
FRA:LIK: Ordinary SharesTotal Employee Number:
314Compare
Compare
Traded in other countries / regions
LIK.Germany IPO Date
2019-03-18Description
Limes Schlosskliniken AG operates mental and psychosomatic mental health clinic. It specializes in the treatment of stress disorders including depressions, Burnout Syndrome, Posttraumatic stress disorder, Anxiety / obsessive-compulsive disorder, eating disorders, personality disorders, and Somatization disorders such as chronic pain. LIMES Schlosskliniken operates in the market for high-quality private hospitals specializing in psychiatry, psychotherapy, and psychosomatics in Germany and Switzerland.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.96 | |||||
Equity-to-Asset | 0.56 | |||||
Debt-to-Equity | 0.42 | |||||
Debt-to-EBITDA | 0.84 | |||||
Interest Coverage | 39.77 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 7.79 | |||||
Beneish M-Score | -2.38 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 19.5 | |||||
3-Year EBITDA Growth Rate | 39.9 | |||||
3-Year EPS without NRI Growth Rate | 10 | |||||
3-Year FCF Growth Rate | -44.9 | |||||
3-Year Book Growth Rate | 30.9 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 49.24 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 26.99 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 52.62 | |||||
9-Day RSI | 53.54 | |||||
14-Day RSI | 54.67 | |||||
3-1 Month Momentum % | 6.25 | |||||
6-1 Month Momentum % | 40.11 | |||||
12-1 Month Momentum % | 42.46 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.79 | |||||
Quick Ratio | 2.77 | |||||
Cash Ratio | 1.46 | |||||
Days Inventory | 7.73 | |||||
Days Sales Outstanding | 50.74 | |||||
Days Payable | 174.81 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.89 | |||||
Forward Dividend Yield % | 1.89 | |||||
5-Year Yield-on-Cost % | 1.9 | |||||
3-Year Average Share Buyback Ratio | -0.6 | |||||
Shareholder Yield % | 0.63 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 91.88 | |||||
Operating Margin % | 18.62 | |||||
Net Margin % | 11.39 | |||||
EBITDA Margin % | 25.59 | |||||
FCF Margin % | 2.28 | |||||
OCF Margin % | 19.55 | |||||
ROE % | 26.01 | |||||
ROA % | 13.4 | |||||
ROIC % | 24.25 | |||||
3-Year ROIIC % | 30.28 | |||||
ROC (Joel Greenblatt) % | 54.23 | |||||
ROCE % | 25.91 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 28.26 | |||||
Forward PE Ratio | 17 | |||||
PE Ratio without NRI | 28.26 | |||||
Price-to-Owner-Earnings | 46.34 | |||||
PEG Ratio | 0.55 | |||||
PS Ratio | 3.22 | |||||
PB Ratio | 6.36 | |||||
Price-to-Tangible-Book | 8.9 | |||||
Price-to-Free-Cash-Flow | 147.5 | |||||
Price-to-Operating-Cash-Flow | 16.56 | |||||
EV-to-EBIT | 17.33 | |||||
EV-to-Forward-EBIT | 10.58 | |||||
EV-to-EBITDA | 12.61 | |||||
EV-to-Forward-EBITDA | 8.64 | |||||
EV-to-Revenue | 3.23 | |||||
EV-to-Forward-Revenue | 2.37 | |||||
EV-to-FCF | 141.77 | |||||
Price-to-GF-Value | 1.05 | |||||
Price-to-Projected-FCF | 5.55 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.13 | |||||
Price-to-Graham-Number | 3.34 | |||||
Earnings Yield (Greenblatt) % | 5.77 | |||||
FCF Yield % | 0.71 | |||||
Forward Rate of Return (Yacktman) % | 20.43 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Limes Schlosskliniken AG Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 49.997 | ||
| EPS (TTM) (€) | 19.11 | ||
| Beta | 1.2583 | ||
| 3-Year Sharpe Ratio | 0.55 | ||
| 3-Year Sortino Ratio | 0.91 | ||
| Volatility % | 37.47 | ||
| 14-Day RSI | 54.67 | ||
| 14-Day ATR (€) | 8.107783 | ||
| 20-Day SMA (€) | 524.65 | ||
| 12-1 Month Momentum % | 42.46 | ||
| 52-Week Range (€) | 3.86 - 545 | ||
| Shares Outstanding (Mil) | 0.3 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Limes Schlosskliniken AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Limes Schlosskliniken AG Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| EUR 10.000000 Cash Dividend | 2026-06-22 | 492.00 (+0.00%) |
Show
Entries
Limes Schlosskliniken AG Frequently Asked Questions
What is Limes Schlosskliniken AG(FRA:LIK)'s stock price today?
The current price of FRA:LIK is €530.00. The 52 week high of FRA:LIK is €545.00 and 52 week low is €3.86.
When is next earnings date of Limes Schlosskliniken AG(FRA:LIK)?
The next earnings date of Limes Schlosskliniken AG(FRA:LIK) is .
Does Limes Schlosskliniken AG(FRA:LIK) pay dividends? If so, how much?
The Dividend Yield %  of Limes Schlosskliniken AG(FRA:LIK) is 1.89% (As of Today), Highest Dividend Payout Ratio of Limes Schlosskliniken AG(FRA:LIK) was 0. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of Limes Schlosskliniken AG(FRA:LIK) is 1.89%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Limes Schlosskliniken AG
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers